167 related articles for article (PubMed ID: 27862274)
1. Risk of Fracture in Primary Aldosteronism: A Population-Based Cohort Study.
Wu VC; Chang CH; Wang CY; Lin YH; Kao TW; Lin PC; Chu TS; Chang YS; Chen L; Wu KD; Chueh SJ
J Bone Miner Res; 2017 Apr; 32(4):743-752. PubMed ID: 27862274
[TBL] [Abstract][Full Text] [Related]
2. Influence of Different Treatment Strategies on New-Onset Atrial Fibrillation Among Patients With Primary Aldosteronism: A Nationwide Longitudinal Cohort-Based Study.
Pan CT; Liao CW; Tsai CH; Chen ZW; Chen L; Hung CS; Liu YC; Lin PC; Chang CC; Chang YY; Wu VC; Lin YH;
J Am Heart Assoc; 2020 Mar; 9(5):e013699. PubMed ID: 32070205
[TBL] [Abstract][Full Text] [Related]
3. Adrenalectomy Improves the Long-Term Risk of End-Stage Renal Disease and Mortality of Primary Aldosteronism.
Chen YY; Lin YH; Huang WC; Chueh E; Chen L; Yang SY; Lin PC; Lin LY; Lin YH; Wu VC; Chu TS; Wu KD
J Endocr Soc; 2019 Jun; 3(6):1110-1126. PubMed ID: 31086833
[TBL] [Abstract][Full Text] [Related]
4. Risk of sepsis in patients with primary aldosteronism.
Chan CK; Hu YH; Chen L; Chang CC; Lin YF; Lai TS; Huang KH; Lin YH; Wu VC; Wu KD;
Crit Care; 2018 Nov; 22(1):313. PubMed ID: 30463626
[TBL] [Abstract][Full Text] [Related]
5. Long term outcome of Aldosteronism after target treatments.
Wu VC; Wang SM; Chang CH; Hu YH; Lin LY; Lin YH; Chueh SC; Chen L; Wu KD
Sci Rep; 2016 Sep; 6():32103. PubMed ID: 27586402
[TBL] [Abstract][Full Text] [Related]
6. Surgery decreases the long-term incident stroke risk in patients with primary aldosteronism.
Chang YH; Chung SD; Wu CH; Chueh JS; Chen L; Lin PC; Lin YH; Huang KH; Wu VC; Chu TS;
Surgery; 2020 Feb; 167(2):367-377. PubMed ID: 31676114
[TBL] [Abstract][Full Text] [Related]
7. Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments.
Wu VC; Wang SM; Huang KH; Tsai YC; Chan CK; Yang SY; Lin LY; Chang CC; Lu CC; Lin YH; Chen YM; Chueh JS
Eur J Endocrinol; 2021 Dec; 186(2):195-205. PubMed ID: 34851859
[TBL] [Abstract][Full Text] [Related]
8. Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years.
Wu VC; Chueh SJ; Chen L; Chang CH; Hu YH; Lin YH; Wu KD; Yang WS;
J Hypertens; 2017 Aug; 35(8):1698-1708. PubMed ID: 28661412
[TBL] [Abstract][Full Text] [Related]
9. Risk of new-onset autoimmune diseases in primary aldosteronism: a nation-wide population-based study.
Er LK; Chen L; Tsai YC; Lin YH; Huang WC; Chang CC; Lu CC; Huang KH; Chueh JS; Wu KD; Wu VC;
J Hypertens; 2020 Apr; 38(4):745-754. PubMed ID: 31764584
[TBL] [Abstract][Full Text] [Related]
10. Risk of dementia in primary aldosteronism compared with essential hypertension: a nationwide cohort study.
Hong N; Kim KJ; Yu MH; Jeong SH; Lee S; Lim JS; Rhee Y
Alzheimers Res Ther; 2023 Aug; 15(1):136. PubMed ID: 37568223
[TBL] [Abstract][Full Text] [Related]
11. Administrative data on diagnosis and mineralocorticoid receptor antagonist prescription identified patients with primary aldosteronism in Taiwan.
Wu VC; Hu YH; Wu CH; Kao CC; Wang CY; Yang WS; Lee HH; Chang YS; Lin YH; Wang SM; Chen L; Wu KD;
J Clin Epidemiol; 2014 Oct; 67(10):1139-49. PubMed ID: 25034196
[TBL] [Abstract][Full Text] [Related]
12. Worsening of lipid metabolism after successful treatment of primary aldosteronism.
Adolf C; Asbach E; Dietz AS; Lang K; Hahner S; Quinkler M; Rump LC; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Reincke M
Endocrine; 2016 Oct; 54(1):198-205. PubMed ID: 27179655
[TBL] [Abstract][Full Text] [Related]
13. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
Lancet Diabetes Endocrinol; 2018 Jan; 6(1):51-59. PubMed ID: 29129576
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism.
Chen KM; Lee BC; Chen PT; Liu KL; Lin KH; Chang CC; Wu TH; Hong JS; Lin YH
Front Endocrinol (Lausanne); 2021; 12():647184. PubMed ID: 34335463
[TBL] [Abstract][Full Text] [Related]
15. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
Hypertension; 2018 Sep; 72(3):658-666. PubMed ID: 29987110
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
[TBL] [Abstract][Full Text] [Related]
17. Primary aldosteronism is associated with risk of urinary bladder stones in a nationwide cohort study.
Chung MC; Lin CL; Wu MJ; Chen CH; Shieh JJ; Chung CJ; Li CY; Yu TM
Sci Rep; 2021 Apr; 11(1):7684. PubMed ID: 33833262
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Mortality for Patients of Primary Aldosteronism Compared With Essential Hypertension: A Systematic Review and Meta-Analysis.
Meng Z; Dai Z; Huang K; Xu C; Zhang YG; Zheng H; Liu TZ
Front Endocrinol (Lausanne); 2020; 11():121. PubMed ID: 32210920
[No Abstract] [Full Text] [Related]
19. Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area.
Chen YY; Feng JY; Ting WY; Yen YF; Chuang PH; Pan SW; Su VY; Su WJ
Osteoporos Int; 2017 May; 28(5):1711-1721. PubMed ID: 28331966
[TBL] [Abstract][Full Text] [Related]
20. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases.
Iwakura Y; Morimoto R; Kudo M; Ono Y; Takase K; Seiji K; Arai Y; Nakamura Y; Sasano H; Ito S; Satoh F
J Clin Endocrinol Metab; 2014 May; 99(5):1593-8. PubMed ID: 24285678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
